{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:46:23Z","timestamp":1762004783418,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.revmed.2015.11.008","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T10:00:49Z","timestamp":1450864849000},"page":"195-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Actualit\u00e9s du traitement de l\u2019ost\u00e9oporose post-m\u00e9nopausique"],"prefix":"10.1016","volume":"37","author":[{"given":"K.","family":"Briot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2015.11.008_bib0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jbspin.2012.02.014","article-title":"2012\u00a0update of French guidelines for the pharmacological treatment of post-menopausal osteoporosis","volume":"79","author":"Briot","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.revmed.2015.11.008_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.revmed.2013.05.007","article-title":"[New French recommendations for the treatment of post-menopausal osteoporosis. What are the implications for the general internists?.]","volume":"35","author":"Blain","year":"2014","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2015.11.008_bib0015","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","article-title":"Meta-analysis: excess mortality after hip fracture among older women and men","volume":"152","author":"Haentjens","year":"2010","journal-title":"Ann Inter Med"},{"key":"10.1016\/j.revmed.2015.11.008_bib0020","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/archinternmed.2011.447","article-title":"Hip fracture and increased short-term but not long-term mortality in healthy older women","volume":"171","author":"Leblanc","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2015.11.008_bib0025","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.2009.50","article-title":"Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women","volume":"301","author":"Bliuc","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2015.11.008_bib0030","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jbspin.2010.11.006","article-title":"Decrease in inpatient mortality for hip fracture in France","volume":"78","author":"Maravic","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.revmed.2015.11.008_bib0035","doi-asserted-by":"crossref","first-page":"e78169","DOI":"10.1371\/journal.pone.0078169","article-title":"Predictors of short and long-term mortality in males and females with hip fracture. A prospective observational cohort study","volume":"8","author":"Diamantopoulos","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2015.11.008_bib0040","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00198-014-3014-9","article-title":"Accelareted bone loss and increased post-fracture mortality in elderly women and men","volume":"26","author":"Bliuc","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.revmed.2015.11.008_bib0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2106\/JBJS.G.01529","article-title":"Proximal humeral fracture as a risk factor for subsequent hip fractures","volume":"91","author":"Clinton","year":"2009","journal-title":"J Bone Joint Surg [Am]"},{"key":"10.1016\/j.revmed.2015.11.008_bib0050","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1007\/s00198-012-1907-z","article-title":"Burden of pelvis fracture: a population-based study of incidence, hospitalization and mortality","volume":"23","author":"Prieto-Alhambra","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.revmed.2015.11.008_bib0055","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archinte.159.11.1215","article-title":"Vertebral fractures and mortality in older women","volume":"159","author":"Kado","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2015.11.008_bib0060","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"Patients with prior fractures have an increased risk of futures fractures: a summary of the literature and statistical synthesis","volume":"15","author":"Klotzbuecher","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.revmed.2015.11.008_bib0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ard.2008.092775","article-title":"Clinical subsequent fractures cluster in time after first fractures","volume":"68","author":"Van Geel","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2015.11.008_bib0070","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.285.3.320","article-title":"Risk of new vertebral fracture in the year following a fracture","volume":"17","author":"Lindsay","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2015.11.008_bib0075","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.1968","article-title":"Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men","volume":"28","author":"Bliuc","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.revmed.2015.11.008_bib0080","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.2106\/JBJS.L.00223","article-title":"Fracture liaison service: impact on subsequent non vertebral fracture incidence and mortality","volume":"96","author":"Huntjens","year":"2014","journal-title":"J Bone Joint Surg [Am]"},{"key":"10.1016\/j.revmed.2015.11.008_bib0085","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00198-011-1534-0","article-title":"Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8\u00a0years of service provision","volume":"22","author":"McLellan","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.revmed.2015.11.008_bib0090","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jbmr.2202","article-title":"Osteoporosis medication use after hip fracture in U.S. patients between 2002\u00a0and 2011","volume":"29","author":"Solomon","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.revmed.2015.11.008_bib0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/RHU.0000000000000154","article-title":"Evaluation of the prescription of osteoporosis treatment after a major osteoporotic fracture","volume":"6","author":"Bouvet","year":"2014","journal-title":"J Clin Rheum"},{"key":"10.1016\/j.revmed.2015.11.008_bib0100","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2217\/ijr.09.59","article-title":"Osteopenia: is it a problem?","volume":"4","author":"Roux","year":"2009","journal-title":"Int J Clin Rheumatol"},{"key":"10.1016\/j.revmed.2015.11.008_bib0105","doi-asserted-by":"crossref","first-page":"e83436","DOI":"10.1371\/journal.pone.0083436","article-title":"FRAX\u00ae: prediction of major osteoporotic fractures in women from the general population: the OPUS study","volume":"8","author":"Briot","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2015.11.008_bib0110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00198-010-1319-x","article-title":"Osteoporosis in inflammatory joint disease","volume":"22","author":"Roux","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.revmed.2015.11.008_bib0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jama.2012.9014","article-title":"Risk of fractures following cataract surgery in medicare beneficiairies","volume":"308","author":"Tseng","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2015.11.008_bib0120","first-page":"1","article-title":"The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults: systematic review and meta-analysis of randomised controlled trials","volume":"347","author":"El-Khoury","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2015.11.008_bib0125","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)61342-7","article-title":"Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50\u00a0years and older: a meta-analysis","volume":"370","author":"Tang","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2015.11.008_bib0130","doi-asserted-by":"crossref","first-page":"C3691","DOI":"10.1136\/bmj.c3691","article-title":"Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis","volume":"341","author":"Bolland","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2015.11.008_bib0135","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.lpm.2011.04.001","article-title":"La vitamine D chez l\u2019adulte: recommandations du GRIO","volume":"40","author":"Benhamou","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2015.11.008_bib0140","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in post-menopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2015.11.008_bib0145","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2015.11.008_bib0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bone.2013.10.006","article-title":"Denosumab compared with risedronate in post-menopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study","volume":"58","author":"Roux","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.revmed.2015.11.008_bib0155","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in post-menopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2015.11.008_bib0160","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamainternmed.2015.0747","article-title":"Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women","volume":"175","author":"Greenspan","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.revmed.2015.11.008_bib0165","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/er.2001-2002","article-title":"Meta analysis of alendronate for the treatment of post menopausal women","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.revmed.2015.11.008_bib0170","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1210\/er.2001-3002","article-title":"Meta analysis of risedronate for the treatment of post menopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endrocr Rev"},{"key":"10.1016\/j.revmed.2015.11.008_bib0175","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00198-013-2433-3","article-title":"How long should we treat?","volume":"25","author":"Roux","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.revmed.2015.11.008_bib0180","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/jbmr.1808","article-title":"Discontinuation of denosumab and associated fracture incidence: analysis from the Fracture reduction evaluation of denosumab in osteoporosis every 6\u00a0months (FREEDOM) trial","volume":"28","author":"Brown","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.revmed.2015.11.008_bib0185","article-title":"Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports","author":"Aubry-Rozier","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.revmed.2015.11.008_bib0190","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jamainternmed.2014.1232","article-title":"Fracture prediction after discontinuation of 4\u00a0to 5\u00a0years of alendronate therapy: the FLEX study","volume":"174","author":"Bauer","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.revmed.2015.11.008_bib0195","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.revmed.2015.11.008_bib0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.revmed.2015.11.008_bib0205","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archinternmed.2012.1796","article-title":"Increasing occurrence of atypical femoral fractures associated with bisphosphonate use","volume":"172","author":"Meier","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2015.11.008_bib0210","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","article-title":"Bisphosphonate use and atypical fractures of the femoral shaft","volume":"364","author":"Schilcher","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2015.11.008_bib0215","article-title":"Absence of recognition of low alkaline phosphatase level in a tertiary care hospital","author":"Maman","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.revmed.2015.11.008_bib0220","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1359\/jbmr.1999.14.8.1449","article-title":"Individual smallest detectable difference in bone mineral density measurements","volume":"14","author":"Ravaud","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.revmed.2015.11.008_bib0225","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(13)60856-9","article-title":"Teriparatide and denosumab, alone or combined, in women with post-menopausal osteoporosis: the DATA study randomized trial","volume":"382","author":"Tsai","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2015.11.008_bib0230","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jbmr.1475","article-title":"Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys","volume":"27","author":"Masarachia","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.revmed.2015.11.008_bib0235","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jbmr.1477","article-title":"Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey","volume":"27","author":"Cusick","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.revmed.2015.11.008_bib0240","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1359\/jbmr.091035","article-title":"Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density","volume":"25","author":"Bone","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.revmed.2015.11.008_bib0245","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/jbmr.1695","article-title":"Odanacatib in the treatment of postmenopausal women with low bone mineral density: five years of continued therapy in a phase 2\u00a0study","volume":"27","author":"Langdahl","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"1147","key":"10.1016\/j.revmed.2015.11.008_bib0250","article-title":"Odanacatib anti-fracture efficacy and safety in postmenopausal women with osteoporosis. Results from the phase III Long-term Odanacatib Fracture Trial (LOFT)","author":"McClung","year":"2014","journal-title":"ASBMR"},{"key":"10.1016\/j.revmed.2015.11.008_bib0255","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.revmed.2015.11.008_bib0260","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2106\/JBJS.L.00285","article-title":"Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model","volume":"95","author":"Virk","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.revmed.2015.11.008_bib0265","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","article-title":"Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody","volume":"26","author":"Padhi","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.revmed.2015.11.008_bib0270","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jcph.239","article-title":"Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study","volume":"54","author":"Padhi","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.revmed.2015.11.008_bib0275","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866315011091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866315011091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:36:08Z","timestamp":1759336568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866315011091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0248866315011091"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2015.11.008","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualit\u00e9s du traitement de l\u2019ost\u00e9oporose post-m\u00e9nopausique","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2015.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}